Pfizer PFE

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines

    Related Topics:

    1. BRIEF-Geratherm Medical: apoplex medical technologies and Pfizer cooperate in field of stroke

      Headlines

      Mon, 18 May 2015

      * Pfizer Pharma GmbH and apoplex medical technologies GmbH have signed today an agreement on a German wide cooperation in field of stroke prevention

    2. Pfizer drug shows early promise in Xalkori-resistant lung cancer-study

      Headlines

      Wed, 13 May 2015

      May 13 (Reuters) - An experimental Pfizer Inc drug that aims to help lung cancer patients with specific genetic mutations who have stopped responding to the company's Xalkori was showing promise in a small, early stage study, according to preliminary data revealed on Wednesday.

    3. BRIEF-DKSH supports Pfizer's expansion to Laos

      Headlines

      Mon, 11 May 2015

      * DKSH Business Unit Healthcare has signed agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos

    4. What we own

      Commentary

      Mon, 4 May 2015

      CLX 3.56 Walmart WMT 3.37 Sysco SYY 3.28 3M MMM 3.20 Suburban Propane SPH 3.16 Johnson & Johnson JNJ 3.06 Pfizer PFE 2.93 Spectra Energy SE 2.89 Coca-Cola KO 2.87 Merk MRK 2.85 General Mills GIS 2.85 Linear Technology LLTC

    5. Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources

      Headlines

      Thu, 30 Apr 2015

      NEW YORK/LONDON (Reuters) - Pfizer Inc is the mystery bidder for Swedish Orphan Biovitrum AB , the rare disease specialist which disclosed this week that a potential buyer had made a preliminary offer, people with knowledge of the situation said.

    6. Incyte Reports Solid 1Q as Attractive Pipeline Continues to Progress

      Commentary

      Thu, 30 Apr 2015

      potential catalyst for the company, we believe it will face a challenging environment given the disappointing launch of Pfizer 's Xeljanz. In addition, its broad Phase II program for its IDO1 inhibitor INCB24360 continues to advance in combination

    7. Bayer Posts Steady 1Q as Health Care Strength Offsets Material Science Weakness

      Commentary

      Thu, 30 Apr 2015

      pipeline. Several of Bayer’s cancer drugs (ODM-201, BAY 86-9766, copanlisib) will enter crowded markets. Also, cardiometabolic drug finerenone holds a similar mechanism of action as Pfizer ’s failed eplerenone.

    8. Icon Reports Solid 1Q, Continued Margin Improvements; Maintaining Fair Value Estimate

      Commentary

      Wed, 29 Apr 2015

      appears to be concerns that the firm's largest customer ( Pfizer ) has added a third preferred contract research organization ..... monitor any changing dynamics in the firm's bookings with Pfizer . Management updated its 2015 guidance to $3.60-3

    9. The Case Against the S&P 500

      Headlines

      Tue, 28 Apr 2015

      the first quarter is because nearly 4% of the index is in Apple ( AAPL ), which advanced by about 13%. Drugmaker Pfizer ( PFE ) is the index’s tenth holding and also had positive performance in the quarter. Over the past 12 months, Apple

    10. UPDATE 1- Pfizer cuts full-year forecast on stronger dollar

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar.

    « Prev12345Next »
    Content Partners